InvestorsHub Logo
Followers 285
Posts 31200
Boards Moderated 0
Alias Born 07/06/2012

Re: jour_trader post# 220042

Friday, 08/05/2016 6:14:39 PM

Friday, August 05, 2016 6:14:39 PM

Post# of 403466
Gee who said the product needed to be abuse proof.....WHOOPSY not the FDA----let's not ignore the FDA FACTS shall we.

http://www.fda.gov/NewsEvents/Newsroom/FactSheets/ucm514939.htm

What makes an opioid abuse-deterrent

Formulations with abuse-deterrent properties target the known or expected routes of abuse, such as crushing in order to snort or dissolving in order to inject, for the specific opioid drug substance. The science of abuse deterrence is relatively new, and both the formulation technologies and the analytical, clinical, and statistical methods for evaluating those technologies are rapidly evolving.

Abuse-deterrent is not the same as abuse-proof

The fact that a product has FDA-approved labeling describing abuse-deterrent properties does not mean the product is impossible to abuse or that these properties necessarily prevent overdose and death – currently marketed technologies do not effectively deter one of the most common forms of opioid abuse – swallowing a number of intact tablets or capsules. Because opioid medications must in the end be able to deliver the opioid to the patient, there may always be some potential for abuse of these products.

Fear Uncertainty and Doubt FUD It Ain't Going To Work Here Anymore. Notice the lack of question mark.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News